---
category: news
title: "Unlearn.AI, a startup developing a ‘digital twin’ service for clinical trials, raises $50M"
excerpt: "That’s perhaps why Unlearn.AI, a startup which today announced that it raised $50 million in a Series B funding round, started with clinical trials. Unlearn’s digital twin product replicates ..."
publishedDateTime: 2022-04-19T11:31:00Z
originalUrl: "https://techcrunch.com/2022/04/19/unlearn-ai-a-startup-developing-a-digital-twin-service-for-clinical-trials-raises-50m/"
webUrl: "https://techcrunch.com/2022/04/19/unlearn-ai-a-startup-developing-a-digital-twin-service-for-clinical-trials-raises-50m/"
ampWebUrl: "https://techcrunch.com/2022/04/19/unlearn-ai-a-startup-developing-a-digital-twin-service-for-clinical-trials-raises-50m/amp/"
cdnAmpWebUrl: "https://techcrunch-com.cdn.ampproject.org/c/s/techcrunch.com/2022/04/19/unlearn-ai-a-startup-developing-a-digital-twin-service-for-clinical-trials-raises-50m/amp/"
type: article
quality: 77
heat: 87
published: true

provider:
  name: TechCrunch
  domain: techcrunch.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/techcrunch.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

images:
  - url: "https://techcrunch.com/wp-content/uploads/2022/04/GettyImages-1266157000.webp?w=1024"
    width: 1024
    height: 682
    isCached: true

related:
  - title: "Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials"
    excerpt: "Unlearn®, developer of the first machine-learning technology that creates digital twins of patients in clinical trials to enable smaller, faster studies, today announced that it has closed a $50 million Series B funding round."
    publishedDateTime: 2022-04-19T11:34:00Z
    webUrl: "https://www.tmcnet.com/usubmit/-unlearn-closes-50-million-series-b-funding-advance-/2022/04/19/9584765.htm"
    type: article
    provider:
      name: TMCnet
      domain: tmcnet.com
    quality: 0

secured: "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;aYv7nEwVrNMR1uKFefpQrA=="
---

